Andrew Tobin

30PUBLICATIONS
116CO-AUTHORS
Medical infection agents (incl. prions)Biomolecular modelling and designCharacterisation of biological macromoleculesChemical and thermal processes in energy and combustionInorganic materials (incl. nanomaterials)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 30, 2026
Low Agonism and Balanced Pathway Modulation Distinguish an M1 Muscarinic Receptor Positive Allosteric Modulator Lacking Cholinergic Adverse Effects.

|Jun 27, 2026
Inhibition of PfCLK3 interferes with malaria parasite RNA splicing and explains the mechanism of action of a new class of antimalarial candidates.

|Jan 31, 2026
Shaping Antimalarials: A Geometry-First Approach to PfCLK3 Covalent Inhibitors.

Skye B Brettell, Carla Fuentes-Guerra Bustos, Saumya Sharma

|Oct 23, 2024
Targeting PfCLK3 with Covalent Inhibitors: A Novel Strategy for Malaria Treatment.

Skye B Brettell, Omar Janha, Abbey Begen

|Aug 14, 2024
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases.

Andrew B Tobin

|Dec 12, 2023
Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner.

Natasja Barki, Laura Jenkins, Sara Marsango

Pageof 5

Frequent Collaborators

12 joint publications

Graeme Milligan

7 joint publications

Patrick M Sexton

4 joint publications

Andrew G Jamieson

4 joint publications

Sophie J Bradley